促红细胞生成素治疗新生儿缺氧缺血性脑病的疗效观察
Effect of erythropoietin on hypoxic ischemic encephalopathy in neonates

DOI: 10.6040/j.issn.1671-7554.0.2015.1200

Keywords: 促红细胞生成素,新生儿,缺氧缺血性脑病,
Hypoxic-ischemic encephalopathy,Neonate,Erythropoietin

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Zhu L, Bai X, Wang S, et al. Recombinant human erythropoietin augments angiogenic responses in a neonatal rat model of cerebral unilateral hypoxia-ischemia[J]. Neonatology, 2014, 106(2): 143-148.
[2]	Eunson P. The long-term health, social, and financial burden of hypoxic-ischaemic encephalopathy[J]. Dev Med Child Neurol, 2015, 57(3): 48-50.
[3]	Pankratova S, Kiryushko D, Sonn K, et al. Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor[J]. Brain, 2010, 133(8): 2281-2294.
[4]	中华医学会儿科学分会新生儿学组. 新生儿缺氧缺血性脑病诊断标准[J]. 中国当代儿科杂志, 2005, 7(2): 97-98.
[5]	金汉珍, 黄德珉, 官希吉. 实用新生儿学[M]. 3版. 北京:人民卫生出版社, 2003:766-771.
[6]	邵肖梅. 早产儿脑损伤和脑性瘫痪[J]. 实用儿科临床杂志, 2003, 3: 163-165.
[7]	范存仁. 婴幼儿智能发育测验手册[M]. 北京: 团结出版社, 1998: 24.
[8]	Jackevicius CA, Fan CS, Warner A. Clinical outcomes of erythropoietin use in heart failure patients with anemia of chronic kidney disease[J]. J Card Fail, 2014, 20(5): 327-333.
[9]	Alexander ML, Hill CA, Rosenkrantz TS, et al. Evaluation of the therapeutic benefit of delayed administration of erythropoietin following early hypoxic-ischemic injury in rodents[J]. Dev Neurosci, 2012, 34(6): 515-524.
[10]	Fang AY, Gonzalez FF, Sheldon RA, et al. Effects of combination therapy using hypothermia and erythropoietin in a rat model of neonatal hypoxia-ischemia[J]. Pediatr Res, 2013, 73(1): 12-17.
[11]	Traudt CM, McPherson RJ, Bauer LA, et al. Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia[J]. Dev Neurosci, 2013, 35(6): 491-503.
[12]	Fan X, van Bel F, van der Kooij MA, et al. Hypothermia and erythropoietin for neuroprotection after neonatal brain damage[J]. Pediatr Res, 2013, 73(1): 18-23.
[13]	Stohlawetz PJ, Dzirlo L, Hergovich N, et al. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans[J]. Blood, 2000, 95(9): 2983-2989.
[14]	Zhu C, Kang W, Xu F, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy[J]. Pediatrics, 2009, 124(2): 218-226.
[15]	Wang X, Chen Y, Kuang D, et al. The cardioprotective effects of erythropoietin in myocardial ischemic injury via upregulation of SDF-1 by JAK2/STAT3[J]. Int J Cardiol, 2012, 156(3): 320-322.
[16]	Nguyen AQ, Cherry BH, Scott GF, et al. Erythropoietin:powerful protection of ischemic and post-ischemic brain[J]. ExpBiol Med(Maywood), 2014, 239(11): 1461-1475.
[17]	Jantzie LL, Miller RH, Robinson S. Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury[J]. Pediatr Res, 2013, 74(6): 658-667.
[18]	Li J, Guo W, Xiong M, et al. Effect of SDF-1/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury[J]. IntJ Mol Med, 2015, 14. doi: 10.3892/ijmm.2015.2344.[Epub ahead of print] PubMed PMID: 26398409.
[19]	蔡清, 薛辛东, 富建华. 新生儿缺氧缺血性脑病研究现状及进展[J]. 中国实用儿科杂志, 2009, 12: 968-971.
[20]	周丛乐, 宋琳琳. 新生儿缺氧缺血性脑病[M] //金汉珍, 黄德珉, 官希吉. 实用新生儿学. 3 版.北京: 人民卫生出版社, 2004:770.

Full-Text